Previous studies have shown that inhibition of ADAM17 reduces renal fibrosis in angiotensin II-induced kidney disease in mice [38], suggesting that ADAM17 and its action to cleave ACE2 may play an important role in kidney disease. Here, AGT is linked to kidney disorder.